Results 181 to 190 of about 12,086 (222)
Some of the next articles are maybe not open access.
Thrombolytic Agents in Critical Care
Critical Care Nursing Clinics of North America, 1993Thrombolytic therapy, when instituted early in optimum dosage, has had an important role in improving the survival of critically ill patients. Thrombolysis is but one component of the processes associated with hemostasis, the mechanism by which humans are protected from death by hemorrhage following injury to a blood vessel.
openaire +2 more sources
1999
In over 90% of cases, a thrombotic occlusion of a coronary artery is the cause of an acute myocardial infarction (AMI) (1). Thrombolytic therapy has been shown to reduce short- and long-term mortality of AMI patients (2). As a result of several large placebo-controlled trials, thrombolysis has become a routine treatment in patients presenting within 6 ...
Uwe Zeymer, Karl-Ludwig Neuhaus
openaire +1 more source
In over 90% of cases, a thrombotic occlusion of a coronary artery is the cause of an acute myocardial infarction (AMI) (1). Thrombolytic therapy has been shown to reduce short- and long-term mortality of AMI patients (2). As a result of several large placebo-controlled trials, thrombolysis has become a routine treatment in patients presenting within 6 ...
Uwe Zeymer, Karl-Ludwig Neuhaus
openaire +1 more source
Thrombolytic, antiplatelet, and antithrombotic agents
The American Journal of Cardiology, 1992The relative efficacy and safety of individual thrombolytic agents, administered alone and with antiplatelet and antithrombotic drugs, in the treatment of acute myocardial infarction are presented. The clinical benefits and risks of treatment choices are discussed in relation to the mechanisms of the formation and prevention of thrombus and ...
openaire +2 more sources
Streptokinase as a thrombolytic agent
The American Journal of Cardiology, 1960A J, JOHNSON, W R, McCARTY
openaire +2 more sources
Nihon Geka Gakkai zasshi, 1984
The clinical efficacy of thrombolytic agents, urokinase, lysyl-plasminogen and batroxobin, was evaluated on the patients with deep venous thrombosis. In the group treated with combination of batroxobin, lysyl-plasminogen and urokinase, significantly better efficacy was obtained over the urokinase group in terms of judgement on venography and clinical ...
openaire +1 more source
The clinical efficacy of thrombolytic agents, urokinase, lysyl-plasminogen and batroxobin, was evaluated on the patients with deep venous thrombosis. In the group treated with combination of batroxobin, lysyl-plasminogen and urokinase, significantly better efficacy was obtained over the urokinase group in terms of judgement on venography and clinical ...
openaire +1 more source
The Biochemistry of Thrombolytic Agents
1985The use of thrombolytic agents for the treatment of acute myocardial infarction has recently received new impetus. There are two major reasons for this. First is the development and perfection of coronary angiography, which allows direct visualization of the acutely thrombosed coronary artery and subsequent administration of thrombolytic agents in ...
openaire +1 more source